Study of Acamprosate in Fragile x Syndrome

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
In this research study we want to understand the effectiveness of a drug treatment, acamprosate, for interfering symptoms (i.e., inattention/hyperactivity, social impairment) associated with Fragile X Syndrome (FXS).
Epistemonikos ID: 8ec9ddc79e4eea3c00a699eb7ed18db2d59c55ed
First added on: May 11, 2024